✦ LIBER ✦

Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia

✍ Scribed by Oliver Meyer; Holger Kiesewetter; Manfred Hermsen; Abdulgabar Salama

Book ID: 114792649
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 62 KB
Volume: 73
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2004.00244.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter to the editor: Effect of IgG anti

Letter to the editor: Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia

✍ William C. Smith 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

Efficacy of rhesus antibodies (anti-Rh0

Efficacy of rhesus antibodies (anti-Rh0 (D)) in autoimmune thrombocytopenia: Correlation with response to high dose IgG and the degree of haemolysis

✍ Panzer, S. ;Gr�mayer, E. R. ;Haas, O. A. ;Niessner, H. ;Graninger, W. 📂 Article 📅 1986 🏛 Springer-Verlag ⚖ 233 KB

We have compared the efficacy of high-dose IgG with that of Rhesus antibodies (anti-Rh0 (D)) in 5 patients with autoimmune thrombocytopenic purpura (3 adults and 2 children). Although only transient, high-dose IgG (0.4 g/kg X 5 days) was effective in all patients (peak values 50-200 X 10(9)/1), wher

Efficacy and safety of subcutaneous tane

Efficacy and safety of subcutaneous tanezumab in patients with pain related to diabetic peripheral neuropathy (NCT01087203)

✍ Bramson, C.; Herrmann, D.; Biton, V.; Carey, W.; Keller, D.; Brown, M.; West, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Safety and efficacy of subcutaneous cert

Safety and efficacy of subcutaneous certolizumab pegol, a new anti-TNFα monoclonal antibody, in patients with moderate-to-severe chronic plaque psoriasis: Preliminary results from a double-blind, placebo-controlled trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

P458 Long-term efficacy and safety of ad

P458 Long-term efficacy and safety of adalumumab in patients with Crohn's disease naïve to prior anti-TNFa therapy compared to prior infliximab failures

✍ Papamichael, K.; Archavlis, E.; Konstantopoulos, P.; Kyriakos, N.; Tsironikos, D 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 51 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB